NEW GROWTH AND INEFFICIENT IMMUNITY.
نویسندگان
چکیده
منابع مشابه
Animal Health - Growth and Immunity
We evaluated anti-Campylobacter activity among 11,790 isolates of lactic acid bacteria from poultry production environments. We measured zones of C. jejuni inhibition surrounding the candidate strains and observed 279 isolates exhibiting antagonism. A Lactobacillus salivarius strain PVD32, was identified and deposited under provisions of the Budapest Treaty (NRRL B-30514). The cell-free, ammoni...
متن کاملGrowth of Massive Black Holes during Radiatively Inefficient Accretion Phases
We derive the black hole mass density as a function of redshift from the hard X-ray AGN luminosity function assuming that massive black holes grow via accreting the circumnuclear gases. The derived black hole mass density matches the measured local black hole mass density at z = 0, which requires the average radiative efficiency of AGNs to be ∼ 0.1 − 0.17. The massive black holes in most faint ...
متن کاملInefficient Diversification ∗
This paper argues that in environments that exhibit non-convexities, risk diversification by financial institutions may be socially inefficient. To this end, we study a stylized, micro-founded model in which individual banks have an incentive to hold diversified portfolios in order to minimize the likelihood of bank runs. Yet, at the same time, diversification may increase the aggregate risk fa...
متن کاملLiquidity and Inefficient Investment
We study consumer liquidity in a general equilibrium model where the friction is the nonpledgeability of future income. Liquidity helps to overcome the absence of a double coincidence of wants. Consumers over-hoard liquidity and the resulting competitive equilibrium is constrained inefficient. Fiscal policy following a large negative shock can increase ex ante welfare. If the government cannot ...
متن کاملInnate immunity and new adjuvants.
Vaccination remains the most cost-effective biomedical approach to the control of infectious diseases in livestock. Vaccines based on killed pathogens or subunit antigens are safer but are often ineffective and require coadministration with adjuvants to achieve efficacy. Unfortunately, most conventional adjuvants are poorly defined, complex substances that fail to meet the stringent criteria fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1913
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)76132-0